TLV Fashion Week Showcases Breast Cancer-Freezing Tech
At this year’s Kornit FAC Tel Aviv Fashion Week, Israel not only showcased new designs, but raised awareness on various social issues for the first time – including breast cancer.
A panel held yesterday (March 20) focused on raising awareness about breast cancer and the latest advancements in early detection and treatment.
Israeli startup IceCure Medical, which has developed technology to freeze and destroy early-stage breast tumors in a short amount of time, showcased its innovation during the panel.
The idea of using an extremely cold liquid to freeze and destroy abnormal tissue – or cryoablation – isn’t new. But IceCure Medical’s system allows physicians to perform the procedure at their own office, with no need for hospitalization.
The breakthrough is the use of liquid nitrogen instead of a mixture of argon and helium gasses. Liquid nitrogen is cheaper, it can be frozen faster, and is easier to maintain at sub-zero temperatures, shortening the treatment time.
Tlalit Bussi Tel Tzure, IceCure’s VP BD and Global Marketing, said: “The technology destroys the tumor without the need for general anesthesia, surgery, or prolonged hospitalization. Thus, significantly reducing pain and the risks associated with surgery and providing excellent cosmetic results.
“The use of imaging devices throughout the freezing process provides doctors with a clearer and more accurate picture than other ablation techniques. The treatment is suitable mainly for those who have a primary tumor, which is smaller than 2 cm in the case of a cancerous tumor and smaller than 4 cm in a targeted and non-metastatic/ benign tumor. The procedure takes less than an hour and can be done in an office-based setting.”
IceCure is currently conducting the largest multi-center clinical trial for the cryoablation of small, low-risk breast cancer. The latest analysis shows that over 96 percent of patients who have undergone the treatment are recurrence-free.